{{Infobox protein family
| Symbol = Bcr-Abl_Oligo
| Name = Bcr-Abl肿瘤蛋白齐聚反应结构域
| image = PDB 1k1f EBI.jpg
| width = 
| caption = Bcr-Abl肿瘤蛋白齐聚反应结构域机制
| Pfam = PF09036
| Pfam_clan =  
| InterPro = IPR015123
| SMART = 
| PROSITE = 
| MEROPS = 
| SCOP = 
| TCDB = 
| OPM family = 
| OPM protein = 
| CAZy = 
| CDD = 
}}
{{PBB|geneid=613}}
'''BCR基因'''（{{lang-en|BCR gene}}），或称'''断裂点簇集区'''（{{lang-en|breakpoint cluster region}}），是[[bcr-abl融合基因|bcr-abl融合基因]]的组成部分之一，其与[[费城染色体|费城染色体]]的形成机制有关。

==病理学==
一个[[22号染色体|22号染色体]]与[[9号染色体|9号染色体]]的相互[[易位|易位]]作用而产生的[[费城染色体|费城染色体]]，它通常在慢性粒细胞性白血病患者体内发现。22号染色体的断裂点就在BCR基因中。这个易位作用产生了一种基于BCR基因和ABL基因进行编码而成的融合蛋白，其基因就位于9号染色体的断裂点上。尽管bcr-abl融合基因已经被广泛研究，但普通的BCR基因机制仍然不明。其蛋白产生一些[[丝氨酸|丝氨酸]]或[[苏氨酸|苏氨酸]]蛋白激酶活动，并是一类p21rac酶活化蛋白。<ref>{{Cite web| title = Entrez Gene: BCR breakpoint cluster region| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=613| accessdate = }}</ref>

Bcr-Abl肿瘤蛋白齐聚反应域（{{lang|en|Bcr-Abl oncoprotein oligomerisation domain}}）位于BCR的[[氨基端|氨基端]]（{{lang|en|N-terminus}}），其为BCR-ABL融合蛋白的齐聚反应必不可少的基因之一。Bcr-Abl肿瘤蛋白齐聚反应域包含一个短状[[氨基端|氨基端]][[α螺旋|α螺旋]]（{{lang|en|alpha-1}}），一个灵活的[[转角|转角]]（{{lang|en|Turn}}）和一个长状的C型α螺旋（{{lang|en|alpha-2}}）。其螺旋体转角使得两个α螺旋能够保持平行定向。这一单体分子的蛋白质结构域，通过一个反平行的卷轴螺旋（{{lang|en|coiled coil}}）形成为一个[[蛋白质二聚体|蛋白质二聚体]]（{{lang|en|protein dimer}}）。其中两个[[α螺旋|α螺旋]]彼此之间发生了结构域对换，其中一个α-1螺旋氨基端进行交换，并挤压另个单体上的α-2螺旋（{{lang|en|alpha-2}}）。两个蛋白质二聚体随后形成一个[[四聚体|四聚体]]（{{lang|en|tetramer}}）<ref name="pmid11780146">{{cite journal | author = Zhao X, Ghaffari S, Lodish H, Malashkevich VN, Kim PS | title = Structure of the Bcr-Abl oncoprotein oligomerization domain | journal = Nat. Struct. Biol. | volume = 9 | issue = 2 | pages = 117-20 | pmid = 11780146 | doi = 10.1038/nsb747 | url = |date=February 2002}}</ref>。

==相互机制==
现今已经发现BCR基因与以下基因发生[[蛋白质交互作用|蛋白-蛋白交互作用]]（{{lang|en|Protein-protein interaction}}）：{{tsl|en|PTPN6|}}<ref name=pmid9788431>{{cite journal |last=Liedtke |first=M |authorlink= |coauthors=Pandey P, Kumar S, Kharbanda S, Kufe D |title=Regulation of Bcr-Abl-induced SAP kinase activity and transformation by the SHPTP1 protein tyrosine phosphatase |journal=Oncogene |volume=17 |issue=15 |pages=1889–92 |publisher= |location = ENGLAND| issn = 0950-9232| pmid = 9788431 |doi = 10.1038/sj.onc.1202117 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |date=Oct  1998}}</ref>、{{tsl|en|XPB|}}<ref name=pmid9874796>{{cite journal |doi=10.1073/pnas.96.1.203 |last=Takeda |first=N |authorlink= |coauthors=Shibuya M, Maru Y |title=The BCR-ABL oncoprotein potentially interacts with the xeroderma pigmentosum group B protein |journal=[[PNAS|Proc. Natl. Acad. Sci. U.S.A.]] |volume=96 |issue=1 |pages=203–7 |publisher= |location = UNITED STATES| issn = 0027-8424| pmid = 9874796 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |pmc=15117 |date=Jan  1999}}</ref>、[[猫肉瘤癌基因|猫肉瘤癌基因]]<ref name=pmid10706130>{{cite journal |last=Lionberger |first=J M |authorlink= |coauthors=Smithgall T E |title=The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl |journal=Cancer Res. |volume=60 |issue=4 |pages=1097–103 |publisher= |location = UNITED STATES| issn = 0008-5472| pmid = 10706130 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |date=Feb  2000}}</ref><ref name=pmid7529874>{{cite journal |last=Maru |first=Y |authorlink= |coauthors=Peters K L, Afar D E, Shibuya M, Witte O N, Smithgall T E |title=Tyrosine phosphorylation of BCR by FPS/FES protein-tyrosine kinases induces association of BCR with GRB-2/SOS |journal=Mol. Cell. Biol. |volume=15 |issue=2 |pages=835–42 |publisher= |location = UNITED STATES| issn = 0270-7306| pmid = 7529874 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |pmc=231961 |date=Feb  1995}}</ref>、{{tsl|en|GRB10|}}<ref name=pmid9747873>{{cite journal |last=Bai |first=R Y |authorlink= |coauthors=Jahn T, Schrem S, Munzert G, Weidner K M, Wang J Y, Duyster J |title=The SH2-containing adapter protein GRB10 interacts with BCR-ABL |journal=Oncogene |volume=17 |issue=8 |pages=941–8 |publisher= |location = ENGLAND| issn = 0950-9232| pmid = 9747873 |doi = 10.1038/sj.onc.1202024 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |date=Aug  1998}}</ref>、{{tsl|en|CD117|}}<ref name=pmid8757502>{{cite journal |doi=10.1046/j.1365-2141.1996.6102053.x |last=Hallek |first=M |authorlink= |coauthors=Danhauser-Riedl S, Herbst R, Warmuth M, Winkler A, Kolb H J, Druker B, Griffin J D, Emmerich B, Ullrich A |title=Interaction of the receptor tyrosine kinase p145c-kit with the p210bcr/abl kinase in myeloid cells |journal=Br. J. Haematol. |volume=94 |issue=1 |pages=5–16 |publisher= |location = ENGLAND| issn = 0007-1048| pmid = 8757502 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |date=Jul  1996}}</ref>、{{tsl|en|Grb2|}}<ref name=pmid7529874/><ref name=pmid9747873/><ref name=pmid10887132>{{cite journal |last=Million |first=R P |authorlink= |coauthors=Van Etten R A |title=The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr/Abl tyrosine kinase |journal=Blood |volume=96 |issue=2 |pages=664–70 |publisher= |location = UNITED STATES| issn = 0006-4971| pmid = 10887132 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |date=Jul  2000}}</ref><ref name=pmid15143164>{{cite journal |last=Million |first=Ryan P |authorlink= |coauthors=Harakawa Nari, Roumiantsev Sergei, Varticovski Lyuba, Van Etten Richard A |title=A direct binding site for Grb2 contributes to transformation and leukemogenesis by the Tel-Abl (ETV6-Abl) tyrosine kinase |journal=Mol. Cell. Biol. |volume=24 |issue=11 |pages=4685–95 |publisher= |location = United States| issn = 0270-7306| pmid = 15143164 |doi = 10.1128/MCB.24.11.4685-4695.2004 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |pmc=416425 |date=Jun  2004}}</ref><ref name=pmid8112292>{{cite journal |last=Puil |first=L |authorlink= |coauthors=Liu J, Gish G, Mbamalu G, Bowtell D, Pelicci P G, Arlinghaus R, Pawson T |title=Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway |journal=EMBO J. |volume=13 |issue=4 |pages=764–73 |publisher= |location = ENGLAND| issn = 0261-4189| pmid = 8112292 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |pmc=394874 |date=Feb  1994}}</ref><ref name=pmid9178913>{{cite journal |last=Ma |first=G |authorlink= |coauthors=Lu D, Wu Y, Liu J, Arlinghaus R B |title=Bcr phosphorylated on tyrosine 177 binds Grb2 |journal=Oncogene |volume=14 |issue=19 |pages=2367–72 |publisher= |location = ENGLAND| issn = 0950-9232| pmid = 9178913 |doi = 10.1038/sj.onc.1201053 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |date=May  1997}}</ref>、{{tsl|en|MLLT4|}}<ref name=pmid12808105>{{cite journal |doi=10.1128/MCB.23.13.4663-4672.2003 |last=Radziwill |first=G |authorlink= |coauthors=Erdmann R A, Margelisch U, Moelling K |title=The Bcr kinase downregulates Ras signaling by phosphorylating AF-6 and binding to its PDZ domain |journal=Mol. Cell. Biol. |volume=23 |issue=13 |pages=4663–72 |publisher= |location = United States| issn = 0270-7306| pmid = 12808105 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |pmc=164848 |date=Jul  2003}}</ref>、{{tsl|en|ABL (gene)|Abl基因}}<ref name=pmid8112292/><ref name=pmid12543778>{{cite journal |last=Ling |first=Xiaoyang |authorlink= |coauthors=Ma Guozhen, Sun Tong, Liu Jiaxin, Arlinghaus Ralph B |title=Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr |journal=Cancer Res. |volume=63 |issue=2 |pages=298–303 |publisher= |location = United States| issn = 0008-5472| pmid = 12543778 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |date=Jan  2003}}</ref><ref name=pmid1712671>{{cite journal |doi=10.1016/0092-8674(91)90148-R |last=Pendergast |first=A M |authorlink= |coauthors=Muller A J, Havlik M H, Maru Y, Witte O N |title=BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner |journal=Cell |volume=66 |issue=1 |pages=161–71 |publisher= |location = UNITED STATES| issn = 0092-8674| pmid = 1712671 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |date=Jul  1991}}</ref>、{{tsl|en|HCK|}}<ref name=pmid12592324>{{cite journal |last=Stanglmaier |first=M |authorlink= |coauthors=Warmuth M, Kleinlein I, Reis S, Hallek M |title=The interaction of the Bcr-Abl tyrosine kinase with the Src kinase Hck is mediated by multiple binding domains |journal=Leukemia |volume=17 |issue=2 |pages=283–9 |publisher= |location = England| issn = 0887-6924| pmid = 12592324 |doi = 10.1038/sj.leu.2402778 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |date=Feb  2003}}</ref><ref name=pmid10849448>{{cite journal |last=Lionberger |first=J M |authorlink= |coauthors=Wilson M B, Smithgall T E |title=Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl is suppressed by kinase-defective Hck |journal=J. Biol. Chem. |volume=275 |issue=24 |pages=18581–5 |publisher= |location = UNITED STATES| issn = 0021-9258| pmid = 10849448 |doi = 10.1074/jbc.C000126200 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |date=Jun  2000}}</ref>、{{tsl|en|SOS1|}}<ref name=pmid7529874/><ref name=pmid8112292/>、{{tsl|en|PIK3CG|}}<ref name=pmid9747873/><ref name=pmid8641358>{{cite journal |last=Salgia |first=R |authorlink= |coauthors=Sattler M, Pisick E, Li J L, Griffin J D |title=p210BCR/ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c-Cbl |journal=Exp. Hematol. |volume=24 |issue=2 |pages=310–3 |publisher= |location = UNITED STATES| issn = 0301-472X| pmid = 8641358 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |date=Feb  1996}}</ref><ref name=pmid7606002>{{cite journal |last=Skorski |first=T |authorlink= |coauthors=Kanakaraj P, Nieborowska-Skorska M, Ratajczak M Z, Wen S C, Zon G, Gewirtz A M, Perussia B, Calabretta B |title=Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells |journal=Blood |volume=86 |issue=2 |pages=726–36 |publisher= |location = UNITED STATES| issn = 0006-4971| pmid = 7606002 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |date=Jul  1995}}</ref>、{{tsl|en|CRKL|}}<ref name=pmid9747873/><ref name=pmid15143164/><ref name=pmid8978305>{{cite journal |last=Heaney |first=C |authorlink= |coauthors=Kolibaba K, Bhat A, Oda T, Ohno S, Fanning S, Druker B J |title=Direct binding of CRKL to BCR-ABL is not required for BCR-ABL transformation |journal=Blood |volume=89 |issue=1 |pages=297–306 |publisher= |location = UNITED STATES| issn = 0006-4971| pmid = 8978305 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |date=Jan  1997}}</ref><ref name=pmid10194128>{{cite journal |last=Kolibaba |first=K S |authorlink= |coauthors=Bhat A, Heaney C, Oda T, Druker B J |title=CRKL binding to BCR-ABL and BCR-ABL transformation |journal=Leuk. Lymphoma |volume=33 |issue=1-2 |pages=119–26 |publisher= |location = SWITZERLAND| issn = 1042-8194| pmid = 10194128 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = | doi=10.3109/10428199909093732|date=Mar  1999}}</ref>和[[桩蛋白|桩蛋白]]<ref name=pmid8641358/><ref name=pmid7534286>{{cite journal |doi=10.1074/jbc.270.10.5039 |last=Salgia |first=R |authorlink= |coauthors=Li J L, Lo S H, Brunkhorst B, Kansas G S, Sobhany E S, Sun Y, Pisick E, Hallek M, Ernst T |title=Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL |journal=J. Biol. Chem. |volume=270 |issue=10 |pages=5039–47 |publisher= |location = UNITED STATES| issn = 0021-9258| pmid = 7534286 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |date=Mar  1995}}</ref>。

==参考==
{{Reflist|2}}

==外部链接==
* {{MeshName|BCR+protein,+human}}

==延伸阅读==
{{Refbegin}}
{{PBB_Further_reading
| citations =
*{{Cite journal  | author=Wang L, Seale J, Woodcock BE, Clark RE |title=e19a2-positive chronic myeloid leukaemia with BCR exon e16-deleted transcripts. |journal=Leukemia |volume=16 |issue= 8 |pages= 1562–3 |year= 2002 |pmid= 12145699 |doi= 10.1038/sj.leu.2402600 }}
}}
{{Refend}}

[[Category:蛋白质域|Category:蛋白质域]]